China
· Delayed Price · Currency is CNY Joincare Pharmaceutical Group Industry Co.,Ltd. Statistics
Total Valuation
Joincare Pharmaceutical Group Industry Co.,Ltd. has a market cap or net worth of CNY 22.51 billion. The enterprise value is 21.61 billion.
| Market Cap | 22.51B |
| Enterprise Value | 21.61B |
Important Dates
The last earnings date was Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jul 18, 2024 |
Share Statistics
Joincare Pharmaceutical Group Industry Co.,Ltd. has 1.87 billion shares outstanding. The number of shares has decreased by -2.18% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.87B |
| Shares Change (YoY) | -2.18% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 10.84% |
| Float | 929.45M |
Valuation Ratios
The trailing PE ratio is 15.31 and the forward PE ratio is 14.74.
| PE Ratio | 15.31 |
| Forward PE | 14.74 |
| PS Ratio | 1.42 |
| PB Ratio | 1.55 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.99, with an EV/FCF ratio of 7.28.
| EV / Earnings | 14.69 |
| EV / Sales | 1.36 |
| EV / EBITDA | 4.99 |
| EV / EBIT | 6.90 |
| EV / FCF | 7.28 |
Financial Position
The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.19 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.24 |
| Debt / FCF | 1.81 |
| Interest Coverage | 23.15 |
Financial Efficiency
Return on equity (ROE) is 13.32% and return on invested capital (ROIC) is 6.89%.
| Return on Equity (ROE) | 13.32% |
| Return on Assets (ROA) | 5.44% |
| Return on Capital (ROIC) | 6.89% |
| Revenue Per Employee | 1.11M |
| Profits Per Employee | 102,380 |
| Employee Count | 14,365 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.08% in the last 52 weeks. The beta is 0.42, so Joincare Pharmaceutical Group Industry Co.,Ltd.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +0.08% |
| 50-Day Moving Average | 10.74 |
| 200-Day Moving Average | 11.33 |
| Relative Strength Index (RSI) | 63.44 |
| Average Volume (20 Days) | 26,943,367 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Joincare Pharmaceutical Group Industry Co.,Ltd. had revenue of CNY 15.89 billion and earned 1.47 billion in profits. Earnings per share was 0.78.
| Revenue | 15.89B |
| Gross Profit | 9.73B |
| Operating Income | 3.13B |
| Pretax Income | 3.61B |
| Net Income | 1.47B |
| EBITDA | 4.30B |
| EBIT | 3.13B |
| Earnings Per Share (EPS) | 0.78 |
Balance Sheet
The company has 15.32 billion in cash and 5.37 billion in debt, giving a net cash position of 9.96 billion or 5.31 per share.
| Cash & Cash Equivalents | 15.32B |
| Total Debt | 5.37B |
| Net Cash | 9.96B |
| Net Cash Per Share | 5.31 |
| Equity (Book Value) | 23.54B |
| Book Value Per Share | 7.73 |
| Working Capital | 12.56B |
Cash Flow
In the last 12 months, operating cash flow was 4.08 billion and capital expenditures -1.11 billion, giving a free cash flow of 2.97 billion.
| Operating Cash Flow | 4.08B |
| Capital Expenditures | -1.11B |
| Free Cash Flow | 2.97B |
| FCF Per Share | 1.58 |
Margins
Gross margin is 61.21%, with operating and profit margins of 19.71% and 9.25%.
| Gross Margin | 61.21% |
| Operating Margin | 19.71% |
| Pretax Margin | 22.69% |
| Profit Margin | 9.25% |
| EBITDA Margin | 27.04% |
| EBIT Margin | 19.71% |
| FCF Margin | 18.68% |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 1.49%.
| Dividend Per Share | 0.18 |
| Dividend Yield | 1.49% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 32.06% |
| Buyback Yield | 2.18% |
| Shareholder Yield | 3.67% |
| Earnings Yield | 6.53% |
| FCF Yield | 13.19% |
Stock Splits
The last stock split was on May 16, 2012. It was a forward split with a ratio of 1.2.
| Last Split Date | May 16, 2012 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Joincare Pharmaceutical Group Industry Co.,Ltd. has an Altman Z-Score of 2.6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.6 |
| Piotroski F-Score | n/a |